A 10-week randomized intervention in 78 healthy adults compared a flexitarian diet including moderate pasture-raised red meat (~3.3 serves/week) against a vegetarian pattern using plant-based meat alternatives (PBMAs). The key finding: plasma docosapentaenoic acid (DPA), a long-chain omega-3, declined significantly in the vegetarian group by week 5 (−6.47 μmol/L, 95% CI: −10.39 to −2.56), with partial recovery by week 10, while remaining stable in the flexitarian group. Critically, no differences in cardiometabolic biomarkers emerged between arms, and among 259 lipid species assessed, only plasmalogen PE-O 39:6 survived multiple-testing correction—declining in the vegetarian group.
This trial addresses a genuinely contested question: whether pasture-raised red meat, which has a meaningfully different fatty acid profile than conventional grain-fed beef, carries the same cardiometabolic risks. The DPA finding matters because DPA is a marine-derived omega-3 with emerging anti-inflammatory and cardiovascular protective properties not replicated by plant-based ALA conversion. The result challenges the assumption that PBMAs are nutritionally equivalent to lean pasture-raised meat—a gap the processed-food industry rarely acknowledges. Limitations are real: the sample is small, the population healthy and young, free-living design limits dietary control, and 10 weeks is insufficient to detect hard endpoints like cardiovascular events. Nevertheless, this is a well-designed RCT with lipidomic depth, and it adds a genuinely incremental but important nuance—context of production and dietary pattern matters enormously when assessing red meat's health profile.